These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 32875945)
1. Universal tumor screening for lynch syndrome: perspectives of patients regarding willingness and informed consent. Subramonian A; Smith D; Dicks E; Dawson L; Borgaonkar M; Etchegary H Per Med; 2020 Sep; 17(5):373-387. PubMed ID: 32875945 [No Abstract] [Full Text] [Related]
2. Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers. Hunter JE; Zepp JM; Gilmore MJ; Davis JV; Esterberg EJ; Muessig KR; Peterson SK; Syngal S; Acheson LS; Wiesner GL; Reiss JA; Goddard KA Cancer; 2015 Sep; 121(18):3281-9. PubMed ID: 26036338 [TBL] [Abstract][Full Text] [Related]
3. Uptake of Genetic Testing Among Patients with Cancer At Risk for Lynch Syndrome in the National Health Interview Survey. Actkins KV; Srinivasan S; Spees LP; Turbitt E; Allen CG; Roberts MC Cancer Prev Res (Phila); 2021 Oct; 14(10):927-932. PubMed ID: 34341014 [TBL] [Abstract][Full Text] [Related]
4. Universal Versus Targeted Screening for Lynch Syndrome: Comparing Ascertainment and Costs Based on Clinical Experience. Erten MZ; Fernandez LP; Ng HK; McKinnon WC; Heald B; Koliba CJ; Greenblatt MS Dig Dis Sci; 2016 Oct; 61(10):2887-2895. PubMed ID: 27384051 [TBL] [Abstract][Full Text] [Related]
5. Universal screening for Lynch syndrome among patients with colorectal cancer: patient perspectives on screening and sharing results with at-risk relatives. Hunter JE; Arnold KA; Cook JE; Zepp J; Gilmore MJ; Rope AF; Davis JV; Bergen KM; Esterberg E; Muessig KR; Peterson SK; Syngal S; Acheson L; Wiesner G; Reiss J; Goddard KAB Fam Cancer; 2017 Jul; 16(3):377-387. PubMed ID: 28176204 [TBL] [Abstract][Full Text] [Related]
6. Clinical guidelines versus universal molecular testing: are we ready to choose an optimal strategy for Lynch syndrome identification? Byfield SA; Syngal S Am J Gastroenterol; 2008 Nov; 103(11):2837-40. PubMed ID: 19032469 [TBL] [Abstract][Full Text] [Related]
7. Suboptimal Adherence in Clinical Practice to Guidelines Recommendation to Screen for Lynch Syndrome. Jain A; Shafer L; Rothenmund H; Kim CA; Samadder J; Gupta S; Singh H Dig Dis Sci; 2019 Dec; 64(12):3489-3501. PubMed ID: 31187321 [TBL] [Abstract][Full Text] [Related]
8. Lynch syndrome screening in newly diagnosed colorectal cancer in general pathology practice: from the revised Bethesda guidelines to a universal approach. Morrison J; Bronner M; Leach BH; Downs-Kelly E; Goldblum JR; Liu X Scand J Gastroenterol; 2011 Nov; 46(11):1340-8. PubMed ID: 21879804 [TBL] [Abstract][Full Text] [Related]
9. Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome. Watkins JC; Yang EJ; Muto MG; Feltmate CM; Berkowitz RS; Horowitz NS; Syngal S; Yurgelun MB; Chittenden A; Hornick JL; Crum CP; Sholl LM; Howitt BE Int J Gynecol Pathol; 2017 Mar; 36(2):115-127. PubMed ID: 27556954 [TBL] [Abstract][Full Text] [Related]
10. Informed consent to microsatellite instability and immunohistochemistry screening for Lynch syndrome. Chubak B; Heald B; Sharp RR Genet Med; 2011 Apr; 13(4):356-60. PubMed ID: 21407081 [TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer survivors' interest in genetic testing for hereditary cancer: implications for universal tumor screening. Cragun D; Malo TL; Pal T; Shibata D; Vadaparampil ST Genet Test Mol Biomarkers; 2012 Jun; 16(6):493-9. PubMed ID: 22224634 [TBL] [Abstract][Full Text] [Related]
12. Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice. Cohen SA; Laurino M; Bowen DJ; Upton MP; Pritchard C; Hisama F; Jarvik G; Fichera A; Sjoding B; Bennett RL; Naylor L; Jacobson A; Burke W; Grady WM Cancer; 2016 Feb; 122(3):393-401. PubMed ID: 26480326 [TBL] [Abstract][Full Text] [Related]
13. Colorectal Cancer Screening Recommendations and Outcomes in Lynch Syndrome. Drogan C; Kupfer SS Gastrointest Endosc Clin N Am; 2022 Jan; 32(1):59-74. PubMed ID: 34798987 [TBL] [Abstract][Full Text] [Related]
14. Changes in screening behaviors and attitudes toward screening from pre-test genetic counseling to post-disclosure in Lynch syndrome families. Burton-Chase AM; Hovick SR; Peterson SK; Marani SK; Vernon SW; Amos CI; Frazier ML; Lynch PM; Gritz ER Clin Genet; 2013 Mar; 83(3):215-20. PubMed ID: 23414081 [TBL] [Abstract][Full Text] [Related]
15. Screening adherence and cancer risk perceptions in colorectal cancer survivors with Lynch-like syndrome. Katz LH; Burton-Chase AM; Advani S; Fellman B; Polivka KM; Yuan Y; Lynch PM; Peterson SK Clin Genet; 2016 Mar; 89(3):392-8. PubMed ID: 26272410 [TBL] [Abstract][Full Text] [Related]
16. Stakeholder Perspectives on Overcoming Barriers to Cascade Testing in Lynch Syndrome: A Qualitative Study. Srinivasan S; Hampel H; Leeman J; Patel A; Kulchak Rahm A; Reuland DS; Roberts MC Cancer Prev Res (Phila); 2020 Dec; 13(12):1037-1046. PubMed ID: 32727822 [TBL] [Abstract][Full Text] [Related]
19. Knowledge and Uptake of Genetic Counseling and Colonoscopic Screening Among Individuals at Increased Risk for Lynch Syndrome and their Endoscopists from the Family Health Promotion Project. Patel SG; Ahnen DJ; Kinney AY; Horick N; Finkelstein DM; Hill DA; Lindor NM; MaCrae F; Lowery JT Am J Gastroenterol; 2016 Feb; 111(2):285-93. PubMed ID: 26856748 [TBL] [Abstract][Full Text] [Related]
20. Genetic counseling and cascade genetic testing in Lynch syndrome. Hampel H Fam Cancer; 2016 Jul; 15(3):423-7. PubMed ID: 26969309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]